LACOG 0419 – NEOSAMBA
Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer Type of Study: Clinical Trial Sponsor / Support: LACOG / GBECAM Primary Objectives: To evaluate in a phase III randomized clinical trial the comparison between an anthracycline-initiated neoadjuvant chemotherapy regimen (AC-T) versus a taxane-initiated regimen (T-AC) in patients with locally advanced HER2- breast cancer Design: Phase […]
LACOG 0221 – BRAVE
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil (LACOG 0221) – BRAVE Study Type of Study: Epidemiological Sponsor / Support: LACOG, GBECAM Primary Objectives: Describe the first-line treatment of hormone receptor-positive, HER2- negative metastatic breast cancer in Brazil. Design: This is an observational, retrospective cohort study. Sample Size: 300 patients Principal Investigator: Gustavo Werutsky Countries […]
GBECAM 0115 – AMAZONA III
Prospective evaluation of breast cancer at Brazilian institutions – Project AMAZONA III Type of Study: Epidemiological Sponsor / Support: LACOG, GBECAM, PRONON Primary Objectives: To describe breast cancer epidemiology in Brazil Design: Observational, prospective, analytical study. Sample Size: 3.000 patients Principal Investigator: Sergio Daniel Simon, Carlos Henrique Barrios, José Bines, Daniela Dornelles Rosa Countries LATAM: Brazil Clinicaltrials.gov Identifier: NCT02663973